Skip to main content
. 2020 Nov 13;115(6):69. doi: 10.1007/s00395-020-00830-y

Fig. 5.

Fig. 5

The PI3 kinase inhibitor wortmannin blocks protection by “background” drugs but not by emricasan. Infarct sizes expressed as percentage of area at risk (AAR). Individual hearts are indicated as grey circles, with the mean and standard error of the mean indicated in black. Statistical analysis was by one-way ANOVA followed by Tukey post test. **p < 0.01, ***p < 0.01 compared to vehicle or as indicated